Diabetes Mellitus, Type 2: Clinical Trials

9994 trials for Diabetes Mellitus, Type 2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6691 completed, 1201 unknown, 708 recruiting, 483 terminated. 3704 Not applicable, 1426 Phase 3, 1183 Phase 4, 1089 Phase 1, 1015 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable3704Completed 2235, Unknown 559, Recruiting 347, Not yet recruiting 179, Active not recruiting 149, Terminated 111, Withdrawn 70, Enrolling by invitation 43, Suspended 11
Phase 31426Completed 1092, Terminated 111, Unknown 86, Recruiting 57, Withdrawn 30, Active not recruiting 26, Not yet recruiting 19, Suspended 4, Enrolling by invitation 1
Phase 41183Completed 803, Unknown 168, Terminated 84, Recruiting 53, Withdrawn 30, Not yet recruiting 23, Active not recruiting 15, Enrolling by invitation 4, Suspended 3
Phase 11089Completed 889, Unknown 67, Terminated 53, Recruiting 39, Active not recruiting 15, Not yet recruiting 15, Withdrawn 10, Suspended 1
Phase 21015Completed 717, Unknown 92, Terminated 83, Recruiting 45, Active not recruiting 31, Withdrawn 28, Not yet recruiting 17, Enrolling by invitation 2
Early Phase 166Completed 39, Unknown 10, Recruiting 7, Active not recruiting 3, Enrolling by invitation 2, Not yet recruiting 2, Terminated 2, Withdrawn 1

Follow this condition Literature Review of Diabetes Mellitus, Type 2 trials Research Report on Diabetes Mellitus, Type 2

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance
Vigabatrin Pill, Placebo oral tablet - Hyperinsulinism, Insulin Resistance
Phase 2WithdrawnUniversity of Arizona2030-04-152025-07-30
MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients
MEDBRIDGE-Guided NCM/CHW Post-Discharge Support Intervention - Type 2 Diabetes, Medication Adherence
Not applicableNot yet recruitingUniversity of Alabama at Birmingham452029-05-012026-05-20
South Asians With Type 2 Diabetes at Risk for Depression
CHW-led T2D Intervention - Type 2 Diabetes
Not applicableNot yet recruitingNYU Langone Health1002027-08-012026-05-19
cfMSC Therapy for Diabetes
cfMSC therapy for diabetes - Type II Diabetes Mellitus
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute302027-06-302026-08-27
Integrating Care for Hypertension-Diabetes MULTImorbidity in Guatemala Through HEARTS Implementation
HEARTS implementation strategies, Supply chain strengthening - Hypertension (HTN), Type 2 Diabetes
Not applicableNot yet recruitingUniversity of Michigan14402027-05-012026-04-17
Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)
ESG with OverStitch - Type 2 Diabetes Mellitus (T2D), Obesity (BMI>30)
Not applicableNot yet recruitingBoston Scientific Corporation502027-04-012026-09-24
Mindful Eating and Mindful Movement for Persons With Type 2 Diabetes Mellitus
Standard of Care Diet and Exercise Group, Mindful Eating and Mindful Movement (MEMO) Group - Type 2 Diabetes
Not applicableNot yet recruitingNortheastern University602027-03-012026-09-18
Glucose, Understanding, Integrated Digital Health, and Engagement (GUIDE) Study
Integrated Digital Health (IDH) platform, Provider engagement - Diabetes, Diabetes Type 2
Not applicableNot yet recruitingYale University3002027-03-012026-09-29
Testing a Diabetes Care Program in Rural and Low-Income Clinics
Community Health Worker-led diabetes program - Type 2 Diabetes Mellitus
Not applicableNot yet recruitingThe University of Texas Medical Branch, Galveston2002027-03-012026-08-14
Tracking Income Dynamics and Everyday Health Study
Preventative health review invitation early in SNAP cycle, Financial counseling invitation early in the SNAP cycle, Aim 3 follow-up call early in the SNAP period - HIV, Hypertension
Not applicableNot yet recruitingUniversity of Pennsylvania4002027-03-012026-10-19
Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes
Continuous Glucose Monitoring (CGM), Adaptive dietary intervention (GEM) - Type 2 Diabetes
Not applicableNot yet recruitingNYU Langone Health1202027-02-012026-08-13
Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
Semaglutide - Diabetes Mellitus, Type 2
Not yet recruitingNovo Nordisk A/S6002027-01-312026-09-18
The Simplified Total-body Resistance Exercise for Muscular Hypertrophy for Diabetic Population (D-STORM)
D-STORM Resistance Training Programme, usual care - Type 2 Diabetes Mellitus (T2DM), Sarcopenia
Not applicableNot yet recruitingUniversiti Teknologi Mara562027-01-012026-06-25
Endoscopic Band Ligation for Type 2 Diabetes Mellitus (ENDOBAND-DM)
Endoscopic Band Ligation (ENDOBAND-DM) - Type 2 Diabetes Mellitus (T2DM)
Not applicableNot yet recruitingEl Katib Hospital102027-01-012026-09-10
Zirconia-Reinforced Glass Ionomer Versus Injectable Giomer in Class V Restorations
Zirconomer, Beautifil Flow Plus X - Class V Dental Caries, Type 2 Diabetes Mellitus, Giomer Technology; Injectable Resin Composite; Zirconia-Modified Glass Ionomer
Not applicableNot yet recruitingCairo University1002027-01-012026-07-28
Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes
Insulin icodec - Type 2 Diabetes
Phase 4Not yet recruitingXi'an International Medical Center Hospital4622027-01-012026-08-05
Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes
pulsENDO Therapy - Diabetes Type 2, Diabetes
Not applicableNot yet recruitingEndogenex, Inc.3202027-01-012026-08-18
Nutrition Intervention Optimization to Better Utilize Resources and Support Health
Meal kits, No-prep meals, Culinary nutrition classes - Diabete Type 2, Obesity & Overweight
Not applicableNot yet recruitingTufts University4002027-01-012026-10-19
Digital Self-Management Education and Support for Young Adults With Type 2 Diabetes (DSMESYAT2DM)
Digital Nurse-Led DSMES Program, Usual Care Plus Standard Digital Education - Type 2 Diabetes Mellitus (T2DM), Diabetes-related Distress
Not applicableNot yet recruitingRecep Turan722026-12-162026-09-03
Diabetes Distress, Medication Adherence Barriers, Self-Management, and Glycemic Control in Adults With Type 2 Diabetes
Diabetes Distress, Medication Adherence Barriers, Diabetes self-managemen - Type 2 Diabetes Mellitus
Not yet recruitingBilecik Seyh Edebali Universitesi1372026-12-152026-10-06

Showing 20 of 9994. Sign in to see all of them.

Narrower conditions

Diabetes Mellitus (1983)  ·  Obesity (1017)  ·  Insulin Resistance (589)  ·  Diabetes Mellitus, Type 1 (438)  ·  Hypertension (359)  ·  Cardiovascular Diseases (315)  ·  Overweight (285)  ·  Motor Activity (277)  ·  Prediabetic State (205)  ·  Renal Insufficiency, Chronic (185)  ·  Metabolic Syndrome (173)  ·  Dyslipidemias (166)  ·  Glucose Intolerance (161)  ·  Hyperglycemia (152)

Broader conditions

Nutritional and Metabolic Diseases (9981)  ·  Endocrine System Diseases (9927)  ·  Metabolic Diseases (9876)  ·  Glucose Metabolism Disorders (9859)  ·  Diabetes Mellitus (8011)  ·  Pathological Conditions, Signs and Symptoms (1801)  ·  Signs and Symptoms (1345)  ·  Nutrition Disorders (1132)  ·  Body Weight (1119)  ·  Overnutrition (1105)  ·  Overweight (828)  ·  Cardiovascular Diseases (764)  ·  Vascular Diseases (746)  ·  Hyperinsulinism (713)  ·  Behavior (574)

Interventions

Metformin (706)  ·  Insulin Glargine (354)  ·  Sitagliptin Phosphate (334)  ·  semaglutide (244)  ·  dapagliflozin (225)  ·  Pioglitazone (208)  ·  Liraglutide (199)  ·  empagliflozin (193)  ·  glimepiride (178)  ·  Exercise (165)  ·  Insulin (154)  ·  Exenatide (148)  ·  Vildagliptin (137)  ·  Insulin Aspart (117)  ·  Insulin Detemir (117)

Sponsors

Novo Nordisk A/S (631)  ·  AstraZeneca (329)  ·  Eli Lilly and Company (235)  ·  Sanofi (184)  ·  Merck Sharp & Dohme LLC (181)  ·  Boehringer Ingelheim (130)  ·  GlaxoSmithKline (129)  ·  Takeda (101)  ·  Pfizer (75)  ·  Novartis Pharmaceuticals (69)  ·  Hoffmann-La Roche (67)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (57)  ·  University of Aarhus (57)  ·  Chong Kun Dang Pharmaceutical (52)  ·  Novartis (47)

Countries

United States (3225)  ·  China (847)  ·  Canada (744)  ·  Germany (743)  ·  United Kingdom (559)  ·  South Korea (536)  ·  Denmark (463)  ·  Mexico (449)  ·  Spain (422)  ·  Italy (412)  ·  France (403)  ·  India (386)  ·  Japan (385)  ·  Poland (344)  ·  Turkey (Türkiye) (328)

Results publications

PMID 38770818, PMID 39963952, PMID 22236356, PMID 25387217, PMID 33166419, PMID 25504028, PMID 35472672, PMID 31903692, PMID 32998732, PMID 32501595, PMID 35044568, PMID 38682786, PMID 22913891, PMID 31606880, PMID 34213819, PMID 23010561, PMID 26894924, PMID 32267058, PMID 39171639, PMID 26580237, PMID 37435938, PMID 24517339, PMID 21450987, PMID 21883806, PMID 22193143, PMID 22234149, PMID 22862847, PMID 23186975, PMID 24786834, PMID 27402391, PMID 27977934, PMID 30615985, PMID 31769496, PMID 31797522, PMID 32324065, PMID 32324082, PMID 32372382, PMID 32648108, PMID 35210595, PMID 39535683, PMID 17878242, PMID 18093207, PMID 19245711, PMID 19491536, PMID 19793357, PMID 21209033, PMID 22055210, PMID 23748506, PMID 24561125, PMID 26691396

NIH funding

2009 (55), 2015 (45), 2008 (41), 2016 (37), 2017 (36), 2019 (35), 2018 (33), 2014 (31), 2023 (30), 2025 (27), 2005 (21), 2004 (5), P30DK111024 (5), R01DK024092 (5), UL1RR024150 (5)